Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer
A Prospective Cohort Study of Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer
Sponsor: Sun Yat-sen University
Terminated
Difficulty accruing subjects the study accrual was closed
Other terminated trials from Sun Yat-sen University
Other Adjuvant Chemotherapy trials with similar outcome
A observational or N/A phase clinical study on Adjuvant Chemotherapy and Breast Cancer, this trial is terminated or withdrawn. The trial is conducted by Sun Yat-sen University and has accumulated 9 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Feb 2021 — Dec 2021 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Recruiting
-
Dec 2018 — Jul 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .